Myriad Genetics (MYGN) Enterprise Value (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Enterprise Value of -$124.4 million for Q1 2026, down 35.51% year-over-year from -$192.9 million in Q1 2025, and up 16.84% quarter-over-quarter from -$149.6 million in Q4 2025.
Myriad Genetics (MYGN) Enterprise Value (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Enterprise Value for 18 consecutive years, with -$124.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 35.51% year-over-year to -$124.4 million; the TTM figure through Mar 2026 stood at -$124.4 million (down 35.51% YoY), while the FY2025 annual figure was -$149.6 million, down 46.09% from the prior year.
- Enterprise Value grew to -$124.4 million in Q1 2026 per MYGN's latest filing, from -$149.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$74.4 million in Q2 2025 and bottomed at -$267.4 million in Q1 2022.
- Historically, Enterprise Value has averaged -$129.1 million across 5 years, with a median of -$114.9 million in 2022.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 51.85% — and 2023, when it soared 70.57%.
- Myriad Genetics' Enterprise Value stood at -$114.9 million in 2022, then declined by 22.63% to -$140.9 million in 2023, then grew by 27.32% to -$102.4 million in 2024, then slumped by 46.09% to -$149.6 million in 2025, then gained by 16.84% to -$124.4 million in 2026.
- Business Quant data shows MYGN's Enterprise Value at -$124.4 million in Q1 2026, -$149.6 million in Q4 2025, and -$145.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | -3.94 Bn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -4.34 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -196.93 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | -1.81 Bn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -1.95 Bn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -1.10 Bn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -1.17 Bn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -51.40 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | -323.00 Mn |
| 10 | Myriad Genetics | 294.22 Mn | 169.82 Mn | 137.60 Mn | -124.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124.40 Mn |
| Dec 31, 2025 | -149.60 Mn |
| Sep 30, 2025 | -145.40 Mn |
| Jun 30, 2025 | -74.40 Mn |
| Mar 31, 2025 | -91.80 Mn |
| Dec 31, 2024 | -102.40 Mn |
| Sep 30, 2024 | -99.90 Mn |
| Jun 30, 2024 | -97.30 Mn |
| Mar 31, 2024 | -104.30 Mn |
| Dec 31, 2023 | -140.90 Mn |
| Sep 30, 2023 | -86.30 Mn |
| Jun 30, 2023 | -121.60 Mn |
| Mar 31, 2023 | -78.70 Mn |
| Dec 31, 2022 | -114.90 Mn |
| Sep 30, 2022 | -191.20 Mn |
| Jun 30, 2022 | -204.10 Mn |
| Mar 31, 2022 | -267.40 Mn |
| Dec 31, 2021 | -338.80 Mn |
| Sep 30, 2021 | -366.20 Mn |
| Jun 30, 2021 | -164.50 Mn |